1-9 of 9
Daniel V.T. Catenacci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exploring New Approaches for Locally Advanced Gastroesophageal Adenocarcinomas: TNT, Irinotecan, and ctDNA

Available to Purchase
Daniel V.T. Catenacci
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6281–6283.
https://doi.org/10.1158/1078-0432.CCR-21-2777
Published: 01 December 2021
View articletitled, Exploring New Approaches for Locally Advanced Gastroesophageal Adenocarcinomas: TNT, Irinotecan, and ctDNA
Open the PDF for Exploring New Approaches for Locally Advanced Gastroesophageal Adenocarcinomas: TNT, Irinotecan, and ctDNA in another window
Journal Articles

A PERFECT Biomarker-focused Study of Neoadjuvant IO for Esophagogastric Cancer

Available to Purchase
Daniel V.T. Catenacci
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (12): 3269–3271.
https://doi.org/10.1158/1078-0432.CCR-21-0324
Published: 15 June 2021
View articletitled, A PERFECT Biomarker-focused Study of Neoadjuvant IO for Esophagogastric Cancer
Open the PDF for A PERFECT Biomarker-focused Study of Neoadjuvant IO for Esophagogastric Cancer in another window
Journal Articles

Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy

Free
Katherine I. Zhou, Bryan Peterson, Anthony Serritella, Joseph Thomas, Natalie Reizine, Stephanie Moya, Carol Tan, Yan Wang, Daniel V.T. Catenacci
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (24): 6453–6463.
https://doi.org/10.1158/1078-0432.CCR-20-2085
Published: 15 December 2020
View articletitled, Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy
Open the PDF for Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Free
Ronan J. Kelly, Jeeyun Lee, Yung-Jue Bang, Khaldoun Almhanna, Mariela Blum-Murphy, Daniel V.T. Catenacci, Hyun Cheol Chung, Zev A. Wainberg, Michael K. Gibson, Keun-Wook Lee, Johanna C. Bendell, Crystal S. Denlinger, Cheng Ean Chee, Takeshi Omori, Rom Leidner, Heinz-Josef Lenz, Yee Chao, Marlon C. Rebelatto, Philip Z. Brohawn, Peng He, Jennifer McDevitt, Siddharth Sheth, Judson M. Englert, Geoffrey Y. Ku
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (4): 846–854.
https://doi.org/10.1158/1078-0432.CCR-19-2443
Published: 14 February 2020
View articletitled, Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Open the PDF for Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing

Available to Purchase
Smita S. Joshi, Daniel V.T. Catenacci, Theodore G. Karrison, Jaclyn D. Peterson, Mark M. Zalupski, Amikar Sehdev, James Wade, Ahad Sadiq, Vincent J. Picozzi, Andrea Amico, Robert Marsh, Mark F. Kozloff, Blase N. Polite, Hedy L. Kindler, Manish R. Sharma
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (1): 18–24.
https://doi.org/10.1158/1078-0432.CCR-19-1483
Published: 03 January 2020
View articletitled, Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing
Open the PDF for Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma

Free
Steven B. Maron, Leah M. Chase, Samantha Lomnicki, Sara Kochanny, Kelly L. Moore, Smita S. Joshi, Stacie Landron, Julie Johnson, Lesli A. Kiedrowski, Rebecca J. Nagy, Richard B. Lanman, Seung Tae Kim, Jeeyun Lee, Daniel V.T. Catenacci
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (23): 7098–7112.
https://doi.org/10.1158/1078-0432.CCR-19-1704
Published: 02 December 2019
View articletitled, Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
Open the PDF for Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel

Free
Jason Willis, Martina I. Lefterova, Alexander Artyomenko, Pashtoon Murtaza Kasi, Yoshiaki Nakamura, Kabir Mody, Daniel V.T. Catenacci, Marwan Fakih, Catalin Barbacioru, Jing Zhao, Marcin Sikora, Stephen R. Fairclough, Hyuk Lee, Kyoung-Mee Kim, Seung Tae Kim, Jinchul Kim, Danielle Gavino, Manuel Benavides, Nir Peled, Timmy Nguyen, Mike Cusnir, Ramez N. Eskander, Georges Azzi, Takayuki Yoshino, Kimberly C. Banks, Victoria M. Raymond, Richard B. Lanman, Darya I. Chudova, AmirAli Talasaz, Scott Kopetz, Jeeyun Lee, Justin I. Odegaard
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (23): 7035–7045.
https://doi.org/10.1158/1078-0432.CCR-19-1324
Published: 02 December 2019
View articletitled, Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Open the PDF for Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel in another window
Includes: Supplementary data
Journal Articles

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

Free
David S. Hong, Patricia LoRusso, Omid Hamid, Filip Janku, Muaiad Kittaneh, Daniel V.T. Catenacci, Emily Chan, Tanios Bekaii-Saab, Shirish M. Gadgeel, Robert D. Loberg, Benny M. Amore, Yuying C. Hwang, Rui Tang, Gataree Ngarmchamnanrith, Eunice L. Kwak
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2403–2413.
https://doi.org/10.1158/1078-0432.CCR-18-1341
Published: 15 April 2019
View articletitled, Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies

Free
Ravi Salgia, Premal Patel, John Bothos, Wei Yu, Steve Eppler, Priti Hegde, Shuang Bai, Surinder Kaur, Ihsan Nijem, Daniel V.T. Catenacci, Amy Peterson, Mark J. Ratain, Blase Polite, Janice M. Mehnert, Rebecca A. Moss
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1666–1675.
https://doi.org/10.1158/1078-0432.CCR-13-2070
Published: 13 March 2014
View articletitled, Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies
Open the PDF for Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies in another window
Includes: Supplementary data